These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9836378)

  • 21. Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
    Sandborn WJ; Hanauer SB
    Inflamm Bowel Dis; 1999 May; 5(2):119-33. PubMed ID: 10338381
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
    Tijhuis GJ; van de Putte LB; Breedveld FC
    Ned Tijdschr Geneeskd; 2001 Sep; 145(39):1880-5. PubMed ID: 11605312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of novel biological therapies in psoriatic arthritis: effects on joints and skin.
    Braun J; Sieper J
    BioDrugs; 2003; 17(3):187-99. PubMed ID: 12749755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etanercept tolerance in a patient with previous infliximab-induced hepatitis.
    Becker H; Willeke P; Domschke W; Gaubitz M
    Clin Rheumatol; 2008 Dec; 27(12):1597-8. PubMed ID: 18795397
    [No Abstract]   [Full Text] [Related]  

  • 25. Tumour necrosis factor-alpha blockade: a new era for effective management of rheumatoid arthritis.
    Hamilton K; Clair EW
    Expert Opin Pharmacother; 2000 Jul; 1(5):1041-52. PubMed ID: 11249494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of differential immunogenicity of tumor necrosis factor inhibitors.
    Anderson P; Louie J; Lau A; Broder M
    Curr Rheumatol Rep; 2005 Mar; 7(1):3-9. PubMed ID: 15760575
    [No Abstract]   [Full Text] [Related]  

  • 27. Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy.
    Gómez-Puerta JA; Sanmartí R; Rodríguez-Cros JR; Cañete JD
    Ann Rheum Dis; 2004 Jul; 63(7):896. PubMed ID: 15194598
    [No Abstract]   [Full Text] [Related]  

  • 28. TNF receptor fusion protein in rheumatoid arthritis.
    O'Brien C
    Mol Med Today; 1996 Jul; 2(7):269. PubMed ID: 8796900
    [No Abstract]   [Full Text] [Related]  

  • 29. Anti-TNFalpha therapy for rheumatoid arthritis: an update.
    Taylor PC
    Intern Med; 2003 Jan; 42(1):15-20. PubMed ID: 12583612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept.
    Mikuls TR; Moreland LW
    Expert Opin Pharmacother; 2001 Jan; 2(1):75-84. PubMed ID: 11336570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour necrosis factor-alpha blockers in rheumatoid arthritis: review of the clinical experience.
    Richard-Miceli C; Dougados M
    BioDrugs; 2001; 15(4):251-9. PubMed ID: 11437690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of inflammatory immunologic disease 3. Anti-TNF therapy in rheumatoid arthritis.
    Takeuchi T
    Intern Med; 2007; 46(16):1311-2. PubMed ID: 17704613
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis.
    Kubota T; Nii T; Nanki T; Kohsaka H; Harigai M; Komano Y; Sugihara T; Nonomura Y; Hirose W; Nagasaka K; Sakurai T; Miyasaka N
    Mod Rheumatol; 2007; 17(6):531-3. PubMed ID: 18084712
    [No Abstract]   [Full Text] [Related]  

  • 34. Which TNF inhibitor for rheumatoid arthritis?
    Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
    [No Abstract]   [Full Text] [Related]  

  • 35. Focus on: biologics that affect therapeutic agents in dermatology.
    Saripalli YV; Gaspari AA
    J Drugs Dermatol; 2005; 4(2):233-45. PubMed ID: 15776786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
    Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
    Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and future use of anti-TNF agents in the treatment of autoimmune, inflammatory disorders.
    Calamia KT
    Adv Exp Med Biol; 2003; 528():545-9. PubMed ID: 12918761
    [No Abstract]   [Full Text] [Related]  

  • 38. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Paradigm shift in the therapy for rheumatoid arthritis and osteoporosis].
    Tanaka Y
    Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2377-9. PubMed ID: 19149029
    [No Abstract]   [Full Text] [Related]  

  • 40. Inhibitors of tumor necrosis factor for rheumatoid arthritis.
    Moreland LW
    J Rheumatol Suppl; 1999 May; 57():7-15. PubMed ID: 10328137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.